Laura obtained her Master in Molecular and Cellular Biology from Sorbonne Université with an M2 specialization in Translationnal Immunology and Biotherapies. She was previously an intern at Institut de la Vision where she stayed as an engineer to work on CRISPR-Cas9 based gene therapy in retina. She is currently involved in Anaëlle’s thesis project, which explores the role of ZBTB38 in mammals, as well as X chromosome inactivation in hES, in collaboration with Claire Rougeulle’s team (Curie Institut).
< Back